Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function
- PMID: 12759801
- DOI: 10.1007/s00213-003-1463-5
Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function
Abstract
Rationale: MDMA (ecstasy; +3,4-methylenedioxymethamphetamine) damages brain serotonin (5-HT) neurons and, in non-human primates, a loss of various 5-HT axonal markers persists for several years. This raises the question of whether long lasting effects occur in human beings that persist even after they have stopped using MDMA.
Objectives: We therefore assessed the effects of an indirect 5-HT manipulation on functions thought to be affected by MDMA use in people who had stopped using MDMA (ex-users) compared with continuing users and non-users.
Methods: Ninety-six participants were recruited: 32 ex-users who had stopped using MDMA for >1 year (mean, 2.4 years); 32 current users and 32 polydrug controls who had never used MDMA but were matched with ex-users and controls on cannabis use and pre-morbid IQ. Participants were given an amino acid mixture that contained either no tryptophan (T-) or augmented tryptophan (T+) and assessed before and 5 h after the drink on measures of cognitive function and mood.
Results: T+ and T- produced plasma tryptophan augmentation and depletion, respectively, in all three groups. Ex-users' plasma tryptophan levels in response to T+ were significantly higher than other groups. Ex-users' performance on a delayed prose recall task improved after T+ and lessened after T-. Changes in ex-users' free plasma tryptophan levels correlated highly (r=-0.9) with their baseline performance on immediate and delayed prose recall; change in total plasma tryptophan correlated (r=-0.81) with delayed recall. Further, total baseline plasma tryptophan correlated with number of years they had used MDMA before quitting. Baseline differences between groups were found on learning, working memory, aggression and impulsivity. T- did not produce differential effects in the three groups.
Conclusions: Our results suggest that prolonged abstinence from MDMA might be associated with altered tryptophan metabolism. Ex-users showing the poorest memory function at baseline were also those who metabolised least tryptophan. These findings may reflect pre-morbid differences in 5-HT function of those who stop using this drug or consequences of MDMA use that emerge after abstention. Aggression is also associated with MDMA use and subsequent abstinence.
Similar articles
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.J Psychopharmacol. 2003 Dec;17(4):371-8. doi: 10.1177/0269881103174014. J Psychopharmacol. 2003. PMID: 14870948
-
Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?Psychopharmacology (Berl). 2002 Jan;159(3):294-303. doi: 10.1007/s002130100907. Epub 2001 Oct 12. Psychopharmacology (Berl). 2002. PMID: 11862362
-
Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.Psychol Med. 2001 May;31(4):647-58. doi: 10.1017/s0033291701003828. Psychol Med. 2001. PMID: 11352367
-
Neuroimaging research in human MDMA users: a review.Psychopharmacology (Berl). 2007 Jan;189(4):539-56. doi: 10.1007/s00213-006-0467-3. Epub 2006 Jul 18. Psychopharmacology (Berl). 2007. PMID: 16847678 Review.
Cited by
-
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Dialogues Clin Neurosci. 2009;11(3):305-17. doi: 10.31887/DCNS.2009.11.3/egmayfrank. Dialogues Clin Neurosci. 2009. PMID: 19877498 Free PMC article. Review.
-
Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.Psychopharmacology (Berl). 2004 May;173(3-4):383-90. doi: 10.1007/s00213-003-1679-4. Epub 2003 Nov 28. Psychopharmacology (Berl). 2004. PMID: 14647960
-
MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.J Psychopharmacol. 2010 Feb;24(2):187-201. doi: 10.1177/0269881109103203. Epub 2009 Mar 20. J Psychopharmacol. 2010. PMID: 19304866 Free PMC article.
-
The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.Psychopharmacology (Berl). 2005 Oct;182(2):262-76. doi: 10.1007/s00213-005-0065-9. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16010539
-
Ecstasy exposure & gender: examining components of verbal memory functioning.PLoS One. 2014 Dec 29;9(12):e115645. doi: 10.1371/journal.pone.0115645. eCollection 2014. PLoS One. 2014. PMID: 25545890 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical